TEKLA CAPITAL MANAGEMENT

Tekla Capital Management LLC is a registered investment adviser based in Boston, Massachusetts, and is currently the investment adviser for two closed-end equity funds, H&Q Healthcare Investors and H&Q Life Sciences Investors. The Funds invest in growth equities, both public and private, in the healthcare and life sciences industries.
TEKLA CAPITAL MANAGEMENT
Social Links:
Industry:
Finance Financial Services Health Care Venture Capital
Founded:
1986-06-01
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Universal Analytics Nginx PHP
Similar Organizations
Alethea Capital Management
Alethea Capital Management is an SEC-registered investment advisor founded in March of 2011
Current Advisors List
Current Employees Featured
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2022-05-10 | Invetx | Tekla Capital Management investment in Series B - Invetx | 60.5 M USD |
2022-04-06 | MoonLake Immunotherapeutics | Tekla Capital Management investment in Post-IPO Equity - MoonLake Immunotherapeutics | 115 M USD |
2022-02-10 | Arkuda Therapeutics | Tekla Capital Management investment in Series B - Arkuda Therapeutics | 64 M USD |
2022-02-07 | Endeavor BioMedicines | Tekla Capital Management investment in Series B - Endeavor BioMedicines | 101 M USD |
2021-11-29 | Quell Therapeutics | Tekla Capital Management investment in Series B - Quell Therapeutics | 156 M USD |
2021-11-09 | Arbor Biotechnologies | Tekla Capital Management investment in Series B - Arbor Biotechnologies | 215 M USD |
2021-11-03 | Parthenon Therapeutics | Tekla Capital Management investment in Series A - Parthenon Therapeutics | 65 M USD |
2021-10-21 | ReCode Therapeutics | Tekla Capital Management investment in Series B - ReCode Therapeutics | 80 M USD |
2021-07-27 | Aristea Therapeutics | Tekla Capital Management investment in Series B - Aristea Therapeutics | 63 M USD |
2021-06-23 | ImmuneID | Tekla Capital Management investment in Series A - ImmuneID | 50 M USD |